Italian pharma group Chiesi to buy US peer KalVista for $1.9 billion
Italian pharma company Chiesi Group will buy U.S.-listed KalVista Pharmaceuticals in an all-cash deal valued at about $1.9 billion, the two companies said in a joint statement on Wednesday.
Open original source